written on 29.05.2014
pt:
Tags:
,

GlaxoSmithKline's India unit eyes sales growth after Novartis vax deal

TAGS: ,

According to a local exec, good times are ahead for Glaxo's vaccines unit in India–and the company's recent pickup of Novartis' non-flu vaccine assets will help it get there.

Latest Report